Pulse Biosciences Inc.

PLSE | NASDAQ

Price Alert Chart Builder DCF Calculator

$53.45

+$1.21 (+2.32%)

Nov 2, 2026, 11:42 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Cash & Equivalents	80.74M	118.04M	44.37M	61.14M	28.61M	12.46M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	8.01M
Long-Term Investments	n/a	n/a	1.89M	-2.73M	-3.26M	n/a
Other Long-Term Assets	691K	677K	-1.52M	365K	365K	365K
Receivables	274K	n/a	n/a	n/a	61K	n/a
Inventory	136K	n/a	n/a	n/a	5.82M	n/a
Other Current Assets	2.28M	1.41M	963K	1.01M	n/a	n/a
Total Current Assets	83.42M	119.45M	45.33M	62.15M	36.63M	22.34M
Property-Plant & Equipment	7.06M	8.32M	8.78M	10.02M	11.25M	11.92M
Goodwill & Intangibles	3.37M	4.01M	4.68M	5.34M	6.01M	6.67M
Total Long-Term Assets	12.69M	13.01M	13.83M	15.73M	17.62M	18.95M
Total Assets	96.11M	132.46M	59.15M	77.88M	54.25M	41.29M
Account Payables	2.78M	1.67M	1.84M	1.57M	2.9M	1.72M
Deferred Revenue	n/a	n/a	n/a	n/a	16K	n/a
Short-Term Debt	1.57M	n/a	n/a	917K	436K	n/a
Other Current Liabilities	1.6M	1.2M	3.2M	50K	1.46M	3.32M
Total Current Liabilities	7.92M	10.06M	6.71M	5.98M	8.52M	7.59M
Long-Term Debt	n/a	n/a	n/a	65M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	7.54M	7.54M	8.09M	74.14M	10.04M	10.81M
Total Liabilities	15.46M	17.6M	14.79M	80.13M	18.56M	18.4M
Total Debt	7.53M	8.9M	9.14M	75.96M	11.25M	11.36M
Book Value	80.66M	114.86M	44.36M	-2.25M	35.69M	22.89M
Book Value Per Share	1.20	1.97	0.92	-0.07	1.28	0.98
Common Stock	68K	66K	55K	37K	29K	25K
Retained Earnings	-463.28M	-390.5M	-336.92M	-294.71M	-236.2M	-172.54M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-1K
Shareholders Equity	80.66M	114.86M	44.36M	-2.25M	35.69M	22.89M
Total Investments	n/a	n/a	1.89M	-2.73M	-3.26M	8.01M